Dr. Allison H. Bartlett, MD, MS, FAAP, is a pediatric infectious diseases specialist at the University of Chicago Medicine Comer Children’s Hospital. She grew up in Madison, Wisconsin and attended Princeton University with a major in molecular biology and a minor in Latin American Studies, graduating with Highest Honors in 1998. She graduated from Washington University School of Medicine in 2002 and completed her training in pediatrics and pediatric infectious diseases at Texas Children’s Hospital/Baylor College of Medicine in 2005 and 2008, respectively. After three years on the faculty at Texas Children’s, she was recruited in 2011 to the University of Chicago Medical Center to join the Section of Pediatric Infectious Diseases as well as the Infection Control and Prevention and Antimicrobial Stewardship Programs. She was promoted to Associate Professor in 2018.
First and foremost, Dr. Bartlett is an astute and caring clinician who strives to provide patient- and family-centered, evidence-based, high-value care to all her patients. She is a role model for trainees and colleagues of the value of interprofessional collaboration and communication.
In addition to her clinical and teaching responsibilities, she has several administrative roles. As the Associate Medical Director of Infection Control, she is the primary content expert for pediatric issues, and also participates in medical center-wide initiatives regardless of patient population. She created, developed and grew the pediatric Antimicrobial Stewardship program. In 2018, she handed over leadership of the pediatric Antimicrobial Stewardship Program to Dr. Madan Kumar, and serves as his mentor.
She has built on the expertise developed working with the Infection Control and Antimicrobial Stewardship programs and expanded the scope of her responsibilities to include departmental and institutional positions in quality improvement and patient safety. She was appointed Quality Chief for the Department of Pediatrics in 2014, and works with faculty, staff, and trainees to improve the quality, safety and efficiency of care that we provide to our patients. In 2017, she was named Executive Medical Director for High Reliability Care, and leads the institutional ‘High Reliability’ program to develop a system-wide approach to eliminate clinically unwarranted variation and provide perfect care for every patient at the highest value.
Dr. Bartlett lives in Hyde Park with her husband and their three sons. She and her family enjoy escaping the city and heading to the North Woods of Wisconsin in the summer for outdoor recreation: hiking, canoeing, swimming, fishing, sailing, and more.
Infectious Diseases Society of America Leadership Institute
Arlington, VA
- Leadership
2019
Epic (Physician Builder)
Verona, WI
- Physician Builder - Analytic
2018
Intermountain Healthcare
Salt Lake City
- Quality Improvement and Patient Safety
2017
Baylor College of Medicine
Houston, TX
MS - Clinical Investigation
2011
Baylor College of Medicine / Texas Children's Hospital
Houston ,TX
- Pediatric Infectious Diseases
2008
Baylor College of Medicine / Texas Children's Hospital
Houston, TX
- Pediatrics
2005
Washington University School of Medicine
St. Louis, MO
MD - Medicine
2002
Princeton University
Princeton, NJ
AB - Molecular Biology
1998
Describing the Heterogeneity of Clinical Utilization of Congenital Syphilis Diagnostic Modalities Among Major United States Tertiary Children's Hospitals, 2017-2022.
Describing the Heterogeneity of Clinical Utilization of Congenital Syphilis Diagnostic Modalities Among Major United States Tertiary Children's Hospitals, 2017-2022. Sex Transm Dis. 2024 Dec 01; 51(12):780-783.
PMID: 39046167
Staphylococcal Toxic Shock Syndrome in a Burned Child Treated with an Antimicrobial Foam Dressing: A Case Report.
Staphylococcal Toxic Shock Syndrome in a Burned Child Treated with an Antimicrobial Foam Dressing: A Case Report. J Burn Care Res. 2023 03 02; 44(2):471-473.
PMID: 36566468
Clostridioides difficile colonization and the frequency of subsequent treatment for C. difficile infection in critically ill patients.
Clostridioides difficile colonization and the frequency of subsequent treatment for C. difficile infection in critically ill patients. Infect Control Hosp Epidemiol. 2023 Nov; 44(11):1782-1787.
PMID: 36658099
Staphylococcal toxic shock syndrome in a burned child treated with an antimicrobial foam dressing: a case report.
Coalson ES, Ghosh K, Bartlett AH, Gottlieb LJ, Vrouwe SQ. Staphylococcal toxic shock syndrome in a burned child treated with an antimicrobial foam dressing: a case report. J Burn Care Res. 2022 Dec 25.
PMID: 36566468
50 Years Ago in TheJournalofPediatrics: Public Health Redux.
50 Years Ago in TheJournalofPediatrics: Public Health Redux. J Pediatr. 2022 09; 248:38.
PMID: 36116855
A Preliminary, Single-Center Retrospective Chart Review of Infusion Times of Intravenous Immune Globulin in Kawasaki Disease and Clinical Outcomes.
A Preliminary, Single-Center Retrospective Chart Review of Infusion Times of Intravenous Immune Globulin in Kawasaki Disease and Clinical Outcomes. J Pediatr Pharmacol Ther. 2022; 27(5):415-418.
PMID: 35845563
A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia.
A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia. Sci Rep. 2022 05 06; 12(1):7429.
PMID: 35523855
Use of clinical pathways integrated into the electronic health record to address the coronavirus disease 2019 (COVID-19) pandemic.
Use of clinical pathways integrated into the electronic health record to address the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol. 2023 02; 44(2):260-267.
PMID: 35314010
Hand Hygiene Compliance Rate During the COVID-19 Pandemic.
Hand Hygiene Compliance Rate During the COVID-19 Pandemic. JAMA Intern Med. 2021 07 01; 181(7):1006-1008.
PMID: 33900357
SHEA Pediatric Leadership Council commentary: Inpatient visitor considerations for pediatric patients during the coronavirus disease 2019 (COVID-19) pandemic.
SHEA Pediatric Leadership Council commentary: Inpatient visitor considerations for pediatric patients during the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol. 2021 11; 42(11):1369-1371.
PMID: 34112274
Award for Excellence in Interdisciplinary Collaboration
University of Chicago Medicine
2019